CPC
IDXX icon

CFC Planning Company’s Idexx Laboratories IDXX Stock Holding History

CFC Planning Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
2,369
+749
+46% +$420K 0.73% 41
2026
Q1 		$910K Buy
1,620
+265
+20% +$170K 0.65% 43
2025
Q4 		$917K Buy
1,355
+397
+41% +$270K 0.7% 39
2025
Q3 		$612K Sell
958
-261
-21% -$158K 0.5% 41
2025
Q2 		$654K Sell
1,219
-101
-8% -$48.3K 0.62% 36
2025
Q1 		$554K Buy
1,320
+143
+12% +$62.1K 0.59% 41
2024
Q4 		$487K Buy
+1,177
New +$516K 0.52% 41

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

CFC Planning Company's IDXX Position: Q2 2026 in Review

CFC Planning Company increased its Idexx Laboratories (IDXX) stake by 46% in Q2 2026, buying an estimated $420K and bringing the position to 2,369 shares worth $1.25M. The position accounts for 0.73% of the portfolio, ranked #41.

CFC Planning Company first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • CFC Planning Company held 2,369 shares of Idexx Laboratories worth $1.25M as of Q2 2026.
  • CFC Planning Company bought 749 Idexx Laboratories shares in Q2 2026, an estimated $420K.
  • Idexx Laboratories made up 0.73% of CFC Planning Company's portfolio in Q2 2026, its #41 holding.
  • CFC Planning Company first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on CFC Planning Company's 13F filing for Q2 2026, filed 5 Aug 2026.